Abstract
We employ a stable isotope strategy wherein both histones and their methylations are labeled in synchronized human cells. This allows us to differentiate between old and new methylations on pre-existing versus newly synthesized histones. The strategy is implemented on K79 methylation in an isoform-specific manner for histones H3.1, H3.2, and H3.3. Although levels of H3.3K79 monomethylation are higher than that of H3.2/H3.1, the rate of establishing the K79 methylation is the same for all three isoforms. Surprisingly, we find that pre-existing “old” histones continue to be K79-monomethylated and -dimethylated at a rate equal to the newly synthesized histones. These observations imply that some degree of positional “scrambling” of K79 methylation occurs through the cell cycle.
Keywords: Cell Cycle, Chromatin Histone Modification, DNA Replication, Histone Methylation, Kinetics, Mass Spectrometry (MS)
Introduction
Histones are subject to myriad post-translational modifications. The most prominent among these modifications are acetylation, methylation, phosphorylation, and ubiquitination. Different modifications are preferentially associated with different regions of the genome, such as euchromatin and heterochromatin, or promoter regions and gene bodies (1–3). Some combinations of modifications have been shown to have linked functional outcomes (4), suggesting that the array of modifications associated with a gene is instrumental in the control of transcriptional activity of that gene both then and for progenitor cells (5).
Histone post-translational modifications have been studied for over 30 years (6). The information obtained can broadly be divided into the global and the local; antibodies to a particular modification can provide a global read-out of levels across the genome, and chromatin immunoprecipitation (ChIP) of a particular modification followed by quantitative PCR can give highly local information (7). More recent approaches employ ChIP followed by microarray or deep sequencing, allowing modification mapping across the entire genome with high resolution (5, 8–9). Mass spectrometry (MS) has been applied to the global analysis of histone post-translational modifications and can provide a direct readout of the combinatorial forms present endogenously (10–12).
During S phase, the entire genome is replicated. In order to allow this, existing nucleosomes are removed and then partitioned onto the two nascent DNA strands. New H3/H4 histones are provided by the chaperone CAF-1 or HIRA as dimers (13). Old (H3-H4)2 tetramers are disassembled and reassembled by the same chaperones and therefore are at least transiently split into dimers. However, the original tetramer appears to be reformed upon assembly. This conclusion is drawn from fluorescent labeling and radiolabeling of old histones (14–17). Recently, mass spectrometric analysis of epitope-tagged H3 has confirmed that the majority of (H3-H4)2 tetramers remain intact during replication, although a small proportion of H3.3-containing tetramers are split during replication-dependent nucleosome incorporation (18). It is not known whether old histone tetramers are partitioned evenly or randomly onto the new DNA strands. Random partitioning of clusters of old nucleosomes was observed for SV40 minichromosomes after inhibition of protein synthesis (19). It is also unknown whether old histones retain their position on the DNA strand or whether some mixing of position occurs between neighboring nucleosomes.
After population of both copies of the DNA with nucleosomes, the histones will be undermethylated. In order to regain the initial methylation levels, additional histone modification must occur. If the H3/H4 tetramer remains intact and in the same position on the DNA strand, we would expect this additional modification to occur on new H3/H4 tetramers as the old tetramers would retain their prior modified status. Additional modification could occur on either the new or the old H3, especially if the old nucleosome position is altered upon reinstallation of the old nucleosome.
Recently, two different stable isotope labeling approaches have been applied prior to MS to analyze the rate of formation of H4K20 (20) or H3 methylation during DNA replication and to identify the rates of turnover of different H3 methylation sites in cultured mammalian cells (21, 22). We employ a similar approach to these studies; however, in contrast to this earlier work, we label both histones and methyl groups, allowing us to differentiate between new and old methylation on new and old histones. A combination of protein and methyl labels was previously used to facilitate the identification and quantification of methylated peptides (23). Labeled cells are arrested at the start of S phase, prior to release into unlabeled medium. The combination of two different stable isotope labels measured across five time points and the three H3 variants results in considerable complexity. We therefore focus this initial report on the simple case of H3K79 mono- and dimethylation. For simplicity, all light labeling is for new material, and all heavy labels arise from parental histone or old methylations using either heavy Arg or heavy methyl isotopic tags. Dot1 is responsible for H3K79 methylation (24, 25), with H2B ubiquitination at K123 required for K79 di- and trimethylation by Dot1 (26–29). H3K79 is unmethylated prior to incorporation into chromatin (30), with no demethylase yet identified for this site.
EXPERIMENTAL PROCEDURES
Cell Culture
For G1/S phase synchronization, a double thymidine block was used. Therefore, HeLa cells were seeded and cultured for 5 days at 37 °C in heavy DMEM supplemented with [13C6]Arg and [13C1,2H3]Met (Cambridge Isotope Laboratories, Inc.). Thymidine (Sigma) was added to a final concentration of 2 mm, and incubation was maintained for 12 h. The block was released by exchanging the thymidine-containing medium with the heavy DMEM medium. The cells were grown for 12 h before adding thymidine again to 2 mm final concentration for a further 16 h to synchronize the HeLa cells at the G1/S border. The arrest was finally released by refeeding the cells with the thymidine-free light DMEM to allow cell cycle progression.
Fluorescence-activated Cell Sorting Analysis of DNA Content
Aliquots were taken at the indicated time points throughout the 52-h time course, fixed in 70% ethanol, and incubated with RNase A (1 μg/ml) and 20 μg/ml propidium iodide at 37 °C and then analyzed on a BD LSR flow cytometer. 25,000 cells were counted per time point.
Histone Preparation and MS
Histones were recovered from HeLa cells using sulfuric acid extraction, as described previously (31). The histone-enriched samples were fractionated by RPLC using a Jupiter 300-Å C18 4.6-mm column (Phenomenex) at 0.8 ml/min, with MS monitoring (32). A gradient separation was employed: 0–30% B over 30 min; 30–60% B over 100 min (Buffer A: 5% acetonitrile, 0.2% formic acid, 0.1% trifluoroacetic acid; Buffer B: 90% acetonitrile, 0.2% formic acid, 0.1% trifluoroacetic acid). Fractions containing H3.1, H3.2, and H3.3 were concentrated by vacuum centrifugation and digested using Arg-C (Roche Applied Science), according to the manufacturer's instructions. H3 Arg-C peptides were analyzed by nano-LC-Fourier transform-ion cyclotron resonance MS (Eksigent nanoLC and a ThermoFisher Scientific LTQ-FT operating at 12 teslas). Peak intensities and areas were extracted from the raw data using an in-house script, with extensive manual validation. Manual validation consisted of checking peak area as well as both retention time and mass error using Xcalibur software (ThermoFisher Scientific). Differentially SILAC-labeled forms of a peptide were required to co-elute; a mass error of less than or equal to 3 ppm was required for each peptide (in fact, the observed mass errors were mostly below 1 ppm). For each data point, the S.E. was calculated as S.D. × sample number−½.
Nucleosome Calculation
Each diploid cell contains 6 × 109 bp of DNA. Assuming 1 nucleosome/200 bp, this gives 3 × 107 nucleosomes/cell. We injected the equivalent of ∼6 × 1012 nucleosomes/analysis (from ∼2 × 105 cells). The dynamic range for this analysis is ∼3 orders of magnitude, allowing detection of ∼6 × 109 nucleosomes, or 30,000 nucleosomes/cell. (This assumes that both copies of the histone peptide in question are identical in a given nucleosome.)
RESULTS
After 5–6 divisions in medium with heavy arginine (+6 Da) and heavy methyl groups (+4 Da), cells were arrested at the entrance to S phase and released into medium with normal isotopes, with time points taken at 0, 4, 12, 30, and 52 h (Fig. 1, A and B). The mixture of pre-existing and newly synthesized histones and methylations were isolated and fractionated according to histone H3 isoform by reverse-phase LC (Fig. 1C). Digestion with the Arg-C protease liberates a peptide containing the K79 site for interrogation by high resolution LC-Fourier transform-ion cyclotron resonance mass spectrometry (Fig. 1D).
FIGURE 1.
Outline of experimental design.
Overall levels of H3.1 K79 mono- and dimethylation averaged across all five time points are shown in Fig. 2A. These relative levels of methylation remain within 5–10% of their level at the start of the experiment through to the 52 h time point (Fig. 2B). For H3.1, the proportions of 0-, 1-, and 2-methyl forms are ∼88, 11, and 1.5%. The 3-methyl form is present at <0.1%, as detected by LTQ-selected reaction monitoring (supplemental Fig. 1). This is below the limit of detection for Fourier transform MS, which we estimate at 30,000 nucleosomes/cell in these experiments.
FIGURE 2.
Overall H3.1K79 methylation levels. A, all time points combined. B, time points shown separately. All contributions from different stable isotope-labeled forms of the H3.1 73EIAQDFKTDLR83 peptide are combined for each methylation state and normalized according to the total signal at each time point. The averages of [M + 2H]2+ and [M + 3H]3+ values from two biological and two technical replicates are shown for H3.1 (error bars show ±S.E.).
After the completion of one S phase, old (heavy) histones are expected to be diluted 1:1 by new (light) histones. We observe ∼70% old histones at the 12 h time point (supplemental Fig. 2). A similar divergence from the 50% ideal was observed by Scharf et al. (22), although in their case, the deviation was only 60%. Fluorescence-activated cell sorting (FACS) analysis, in combination with mass spectrometric analysis of the extent of SILAC labeling, indicates that this discrepancy results from 35–40% of the cells that fail to enter S phase after release from the thymidine block (supplemental Fig. 5 and supplemental text). We observe ∼93% SILAC label incorporation for both methyl and arginine labels (supplemental Figs. 2–4).
K79 Methylation on Old and New Histone H3
Newly synthesized H3 will be undermethylated at K79. In order for new histones to reach the global monomethylation level (maintained throughout the time course), they need to become ∼11% monomethylated. Fig. 3 shows the methylation status of new histones as the experiment progresses; methylation of new histones is at just 5% after 12 h, well below the 11% global monomethylation level. In Fig. 4A, new methylation is shown as a proportion of total monomethyl K79 levels. We see from Fig. 4A that new methylation of old histones contributes significantly to the overall level of monomethylation (15% of the total at 12 h, compared with 11% from methylation of new histones). Fig. 4B shows mass spectra illustrating the significant contribution of new methylation on old histones.
FIGURE 3.
Proportion of new histone H3.1 that is methylated at K79. The averages of [M + 2H]2+ and [M + 3H]3+ values from two biological and two technical replicates are shown for H3.1 (error bars show ±S.E.). Signal due to incomplete SILAC labeling of old histone is not included (light histones with old methylation). me1:0, 1 light methyl (new); me2:0, 2 light methyl (new).
FIGURE 4.
New K79 monomethylation on new and old histone H3.1. A, average of [M + 2H]2+ and [M + 3H]3+ values from two biological and two technical replicates are shown for H3.1 (error bars show ±S.E.). The majority of cells have completed the first S phase by 12 h and G2/M by 14 h. B, mass spectra of the K79 peptide 73EIAQDFKTDLR83 [M + 2H]2+ from one experiment are shown for H3.1. Peaks are annotated with their percentage contribution to methyl form (i.e. 0-methyl or 1-methyl form). The right-hand side of the mass spectrum is amplified 5-fold, to display the unmethylated and methylated forms in the same figure.
The new methylation on old histones could be due to turnover (demethylation + remethylation) or simply additional, new methylation on the extensive pool of unmodified H3K79. If there is significant methylation turnover, we would expect to see the old histones with old methylation decay faster than the unmodified control peptide. Fig. 5 compares the rates of decay. An H3 peptide that is never modified (YQKSTELLIR) serves as a nice control. The rates of decay of the two species are highly similar (each 1.1%/h). This suggests that levels of K79me1 turnover are not high. The decay of unmodified K79 is slightly more rapid than K79me1 (1.1 versus 1.2% h−1); however, this difference is within the error of measurement.
FIGURE 5.
Rate of change of old K79 unmodified, monomethylated, and control peptide. Proportion of the signal for each K79 methylation form or the control peptide from the old histones is shown for each time point. For comparison, the rate of decay of the unmodified peptide 54YQKSTELLIR63 is reproduced (supplemental Fig. 2). Heavy K79me1 histones make up only 89% of the monomethyl total at t = 0, due to incomplete labeling of either methyl or arginine. The heavy control peptide incorporates only heavy arginine and therefore shows less underlabeling. The averages of [M + 2H]2+ and [M + 3H]3+ values from two biological and two technical replicates are shown for H3.1 (error bars show ±S.E.).
K79 dimethylation shows similar trends for the formation of new dimethylation on previously unmodified new and old histones (Fig. 6). Interestingly, a significant amount of new methylation occurs on old K79me1, creating mixed heavy/light K79me2.
FIGURE 6.
New K79 dimethylation on new and old histone H3.1. Average of [M + 2H]2+ and [M + 3H]3+ values from two biological and two technical replicates are shown for H3.1 (error bars show ±S.E.). me2:1, 2 methyl: 1 light and 1 heavy; me2:0, 2 light methyl (new).
Rates of Change of Methylation
Rates of change of methylation during the first, synchronized cell cycle were calculated by fitting a straight line to the first three data points (through to 12 h; Table 1). Restricting the analysis to the first cell cycle allows comparison between new and old histones. In the second and subsequent cell cycles, old histones are diluted and degraded, resulting in reduced contribution to the overall pool (Figs. 4 and 6). The rate of increase of unmethylated K79 is greater than that of monomethylated K79, which is greater than that of dimethylated K79. This is consistent with the recent findings of Zee et al. (21). Because the rate of de novo production of all-light dimethylated K79 is lower than that of monomethyl K79, this might suggest that the rate of new dimethylation site creation (i.e. K79me2 turnover) is lower than that of monomethylation. In fact, this is not the case. New K79me2 sites can be formed from existing K79me1 sites on old (heavy) histones (Fig. 6). Any methylation site that incorporates at least one light methyl group is, by definition, “new” (with the caveat that a small proportion of light methyl exists at t = 0 h, due to incomplete, 93–95%, heavy methyl labeling). When this additional source of new methylation is taken into account, the rates for K79me1 and K79me2 production are seen to be similar (Fig. 7).
TABLE 1.
Rate of increase of new methylation on either old or new histone
The rate of increase of new unmodified K79 and the control peptide YQKSTELLIR are shown at the top for comparison. Rates are calculated from 0–12 h data from H3.1 (Figs. 4, 6, and 7 and supplemental Fig. 1). The numbers after the colons indicate the number of heavy, “old” methyl groups) and are presented as percentage/h and days to half-maximum new methylation with S.E.
| Species | Gradient | Days to half-maximum (S.E.) |
|---|---|---|
| %/h | ||
| New unmodified K79 | 1.7 | 1.3 (0.2) |
| New 54YQKSTELLIR63 | 1.6 | 1.4 (0.1) |
| New and old K79me1:0 | 1.5 | 1.4 (0.1) |
| New and old K79me2:1, me2:0 | 1.2 | 1.8 (0.2) |
| New K79me1:0 | 0.7 | 2.9 (0.2) |
| Old K79me1:0 | 0.8 | 2.7 (0.3) |
| New K79me2:0 | 0.3 | 8.1 (1.3) |
| Old K79me2:1 | 1.0 | 2.2 (0.1) |
| Old K79me2:0 | 0.1 | 14.1 (0.3) |
FIGURE 7.
Rate of new K79 mono- and dimethylation creation. Proportion of the signal for each K79 methylation form is shown for each time point. me2:1 and me2:0 are combined because both represent dimethylation creation. Averages of [M + 2H]2+ and [M + 3H]3+ values from two biological and two technical replicates are shown for H3.1 (error bars show ±S.E.).
Histone Variants
From separation of intact histone H3 proteins, we observe the proportions of H3.1, H3.2, and H3.3 to be ∼50, 42, and 8%.
H3.3 was previously reported to show higher levels of monomethylation than H3.1 (30). H3.2 and H3.3 differ only in four positions and partially co-elute in our reverse-phase separation. However, Fig. 8 shows that up to 95% pure H3.3 fractions can be obtained. We find the level of H3.3 monomethylation to be higher than H3.1, which is in turn higher than H3.2 (Fig. 9 and Table 2).
FIGURE 8.
Separation of the three H3 isoforms. The chromatogram is taken from a 4 h time point and covers the 890–950 m/z region, incorporating the 17+ H3 charge state. Insets show the diagnostic Arg-C peptide (residues 27–40 with four methyl groups; 3+), indicating the purity of digested fractions.
FIGURE 9.
Overall H3.1-, H3.2-, and H3.3K79 monomethylation levels. All contributions from different stable isotope-labeled forms of the 73EIAQDFKTDLR83 peptide are combined for each methylation state and normalized according to the total signal at each time point. Average of [M + 2H]2+ and [M + 3H]3+ values from two biological replicates are shown for H3.2 and H3.3. Average of [M + 2H]2+ and [M + 3H]3+ values from two biological and two technical replicates are shown for H3.1 (error bars show ±S.E.).
TABLE 2.
Overall methylation levels of H3.1, H3.2, and H3.3
All contributions from different stable isotope-labeled forms of the 73EIAQDFKTDLR83 peptide are combined for each methylation state and normalized according to the total signal at each time point. The averages of [M + 2H]2+ and [M + 3H]3+ values at all time points from two biological replicates are shown for H3.2 and H3.3. The averages of [M + 2H]2+ and [M + 3H]3+ values at all time points from two biological and two technical replicate are shown for H3.1.
| Variant | 0 methyl | 1 methyl | 2 methyl |
|---|---|---|---|
| H3.1 | 87.8 | 10.7 | 1.5 |
| H3.2 | 91.7 | 7.3 | 1.0 |
| H3.3 | 76.5 | 21.0 | 2.5 |
Rates for H3.2 and H3.3 are shown in Tables 3 and 4. All three isoforms show broadly similar rates of new methylation appearance.
TABLE 3.
Rate of increase of new methylation on either old or new histone H3.2
The rate of increase of new unmodified K79 and the control peptide YQKSTELLIR are shown at the top for comparison. Rates are calculated from 0–12 h data from H3.2 (the numbers after the colons indicate the number of heavy, “old” methyl groups).
| Species | Gradient | Days to half-maximum (S.E.) |
|---|---|---|
| %/h | ||
| New unmodified K79 | 1.6 | 1.3 (0.1) |
| New 54YQKSTELLIR63 | 1.7 | 1.3 (0.1) |
| New and old K79me1:0 | 1.7 | 1.2 (0.1) |
| New and old K79me2:1, me2:0 | 2.0 | 1.2 (0.4) |
| New K79me1:0 | 0.7 | 3.0 (0.3) |
| Old K79me1:0 | 1.0 | 2.1 (0.4) |
| New K79me2:0 | 0.1 | 17.9 (4.7) |
| Old K79me2:1 | 1.5 | 1.6 (0.5) |
| Old K79me2:0 | 0.4 | 6.6 (2.3) |
TABLE 4.
Rate of increase of new methylation on either old or new histone H3.3
Rate of increase of new unmodified K79 and the control peptide YQKSTELLIR are shown in the top row for comparison. Rates are calculated from 0–12 h data from H3.3 (the numbers after the colons indicate number of heavy, “old” methyl groups).
| Species | Gradient | Days to half-maximum (S.E.) |
|---|---|---|
| %/h | ||
| New unmodified K79 | 1.7 | 1.3 (0.2) |
| New 54YQKSTELLIR63 | 1.4 | 1.5 (0.2) |
| New and old K79me1:0 | 1.7 | 1.2 (0.0) |
| New and old K79me2:1, me2:0 | 1.9 | 1.1 (0.1) |
| New K79me1:0 | 0.6 | 3.9 (0.6) |
| Old K79me1:0 | 1.2 | 1.8 (0.1) |
| New K79me2:0 | 0.2 | 9.8 (2.8) |
| Old K79me2:1 | 1.3 | 1.8 (0.5) |
| Old K79me2:0 | 0.3 | 6.4 (0.3) |
DISCUSSION
K79 Methylation Levels throughout the Cell Cycle
Using an antibody raised against an H3 K79me2 peptide, Feng et al. (24) have observed a slight decrease in K79me2 during S phase and G2 in HeLa cells. By contrast, Schulze et al. (33) found that K79me2 levels in Saccharomyces cerevisiae increased during S phase and peaked at the G2/M phase boundary. We observe approximately constant levels of H3K79 methylation at the 0, 4, 12, and 30 h time points. The fact that no drop in K79 methylation levels is observed at the 4 or 12 h time points suggests that new K79 methylation occurs with S phase or shortly after; K9 methylation is known to be deposited with the insertion of new histones (34).
Re-establishment of K79 Methylation Involves New Methylation of Old Histones
Approximately 35% of the cells do not re-enter the cell cycle. These non-cycling cells do not contribute any significant additional methylation or show additional non-replication dependent H3.3 incorporation (see supplemental text). The non-cycling cells also do not contribute new replication-dependent histones to the mass spectra. Therefore, the intensity of signals from the majority of cells that are cycling will be diluted.
The global amount of K79 methylation does not change significantly throughout the 52 h followed in this study. The simplest assumption is that the positioning of the majority of K79 methylation throughout the genome remains approximately constant. Various schemes have been envisaged for the repositioning of old histones and the introduction of new histones after passage of the DNA replication fork. In the simplest model, old (H3-H4)2 tetramers remain intact and are returned to the same loci on the nascent strands, with gaps filled in by new histones (Scheme 1). In this model restoration of K79 methylation status would require only new methylation of new H3. This does not agree with our data. Fig. 3 shows that methylation of new histones is only 5% after 12 h, well below the 11% global monomethylation level. This agrees with the findings of Scharf et al. (22) that K79 monomethylation on new histones is substantially lower than that on old histones after a complete S phase. The labeling strategy of Scharf et al. (22) could not distinguish new from old methylation on old histones, however. We see that a large amount of new methylation occurs on old histones during S/G2 phase: 15% of total monomethyl at 12 h, compared with 11% of the total on new histones (Fig. 4). This would fit with a simple model where new chromatin is methylated at K79 evenly on new and old histones, with the additional methylation of old histones being due to turnover of existing K79 methylation and/or underlabeled old histones with old methyl.
SCHEME 1.
H3/H4 tetramers remain intact during DNA replication.
Because there is 10-fold more unmodified K79 than K79me1, additional methylation of a small fraction of unmodified K79 can account for a relatively large increase in K79me1. We observe a 0.1% h−1 faster rate of decay for the unmodified K79 peptide (Fig. 5). If the 0.1% h−1 faster rate of decay of unmodified old K79 compared with the control heavy peptide is due to new methylation, this would contribute 12% of the total monomethyl pool by 12 h. This very small increased rate of decay is sufficient to account for the additional methylation of old histones shown in Fig. 4.
Equal methylation on new and old histones implies “scrambling” of methylation position; if new and old tetramers remain distinct and remain in the same positions, then the exact position of K79 monomethylation changes on the new chromatin, and if the nucleosomes do not remain in exactly the same positions after DNA replication, this also implies that the position of methylation (old methylation, in this case) is altered. Analysis of K79 dimethylation also provides evidence for position scrambling and robust methylation of old histone H3 at K79. A large proportion of the total dimethyl K79 pool at 12 h (24%) is due to new additional methylation of old K79me1 H3 (Fig. 6). This implies that either the nucleosome localization is altered after replication, or the dimethyl/monomethyl location is altered. Scheme 2 shows alteration of the methylation position, allowing new methylation of old and new histones. This “scrambling” explanation requires the availability of unmethylated, old histone H3 flanking sites of K79 methylation. This could be as either unmethylated nucleosomes or hemimethylated nucleosomes (i.e. only one copy of H3 has K79me), both of which are shown in Scheme 2. Highly dense regions of H3 K79me1, where every available H3 is monomethylated, would not allow sufficient additional methylation of old H3 to explain our data. Steger et al. (35) used a ChIP-chip tiling array approach to show that K79me1 extends across the body of transcriptionally active genes, over tens of thousands of nucleotides and therefore several hundred nucleosomes. Although the available ChIP-chip and ChIP-Seq data on K79 methylation give good localization information (9, 35), it is not straightforward to estimate the density of K79me1, given that the data are an average of many cells, the majority of methylated nucleosomes are not strongly positioned (36), and two copies of H3 are present in each nucleosome.
SCHEME 2.
Position of methylation altered during DNA replication.
An alternative scheme envisages the old (H3-H4)2 tetramers being separated into dimers and coupled with new H3-H4 dimers on the nascent DNA strands (Scheme 3). Although this semiconservative model is conceptually attractive in terms of propagating epigenetic information and permits new methylation of old histones, the vast majority of experimental evidence argues against splitting of the old (H3-H4)2 tetramers in bulk chromatin (14–17). There is some experimental support for a limited amount of tetramer splitting. Kumar and Leffak (37) found that an actively transcribed chromatin fraction, constituting 5% of the total, did show semiconservative replication, as indicated by pulse-labeling and cross-linking. Very recently, Xu et al. (18) have shown that a minority of (H3-H4)2 tetramers are split, in a replication-dependent fashion. They observe this only for H3.3-containing tetramers and note that this may be due to the enrichment of H3.3 tetramers in actively transcribed regions of chromatin rather than a unique property of H3.3 itself. It is interesting to note that K79 methylation is also associated with actively transcribed genes (9, 35, 38). However, given that we see no significant differences between H3.3 and H3.1/H3.2 K79 methylation replication, the simplest conclusion is that our results do not reflect (H3-H4)2 tetramer splitting.
SCHEME 3.
H3/H4 tetramers split after DNA replication.
K79 Dimethylation
Creation of entirely new dimethylation of K79 occurs significantly more slowly than new monomethylation. However, mixed K79 dimethylation, arising from additional methylation of old K79me1, should also be considered. When this is taken into account, there is no significant difference in the production rate of new dimethyl and monomethyl K79 (Fig. 7). It is clear from our data that K79me2 is frequently formed from additional methylation of old K79me1 (Fig. 6). The ChIP-chip tiling array data of Steger et al. (35) show that K79me2 peaks at the transcriptional start site. This is within a broader region of K79me1. Consistent with our data is the finding that at the same loci, K79me1 levels decrease as K79me2 levels increase upon induction of gene expression (35).
Rates and Levels of Methylation across H3 Isoforms
We observe distinct levels of K79 methylation on the three H3 isoforms; H3.3 shows the highest levels, followed by H3.1 and then H3.2. The high levels of H3.3K79 methylation are consistent with earlier reports and with K79 methylation being associated with gene expression (9, 30, 38). The global level of K79 methylation is considerably higher in S. cerevisiae; in this case, only one H3 is present (H3.3-like), and a high proportion of the genome is actively transcribed (25). One could use yeast H3 to verify the initial finding here that robust methylation occurs on old histones.
In general, the rates of production for the various K79 methylated species are similar across the three H3 isoforms. This is consistent with the same methyltransferase, Dot1, acting on all three isoforms.
Overall Perspective
The use of heavy and light labels for methylation studies using stable isotopes produced 12 different MS signals for just K79 unmodified, K79me1, and K79me2 in this study. For other sites, hundreds of data channels are formed for the Lys and Arg methylation sites on histones H3 and H4, with the general data work-up and interpretation presented here now representing a clarified route to measure the turnover rates of all major lysine and arginine methylations on histones. It will be interesting to see how much heterogeneity exists in turnover rates among the 12 major sites of methylation in human cells. Such data will have a major impact on plans for epigenetic treatment in terms of target selection, dosages, and off-target effects (39).
Supplementary Material
Footnotes
This work was supported, in whole or in part, by National Institutes of Health Grant GM 067193-08.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1–5 and supplemental text.
REFERENCES
- 1.Rao B., Shibata Y., Strahl B. D., Lieb J. D. (2005) Mol. Cell. Biol. 25, 9447–9459 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Noma K., Allis C. D., Grewal S. I. (2001) Science 293, 1150–1155 [DOI] [PubMed] [Google Scholar]
- 3.Heintzman N. D., Hon G. C., Hawkins R. D., Kheradpour P., Stark A., Harp L. F., Ye Z., Lee L. K., Stuart R. K., Ching C. W., Ching K. A., Antosiewicz-Bourget J. E., Liu H., Zhang X., Green R. D., Lobanenkov V. V., Stewart R., Thomson J. A., Crawford G. E., Kellis M., Ren B. (2009) Nature 459, 108–112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Fischle W., Tseng B. S., Dormann H. L., Ueberheide B. M., Garcia B. A., Shabanowitz J., Hunt D. F., Funabiki H., Allis C. D., (2005) Nature 438, 1116–1122 [DOI] [PubMed] [Google Scholar]
- 5.Mikkelsen T. S., Ku M., Jaffe D. B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T. K., Koche R. P., Lee W., Mendenhall E., O'Donovan A., Presser A., Russ C., Xie X., Meissner A., Wernig M., Jaenisch R., Nusbaum C., Lander E. S., Bernstein B. E. (2007) Nature 448, 553–560 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Byvoet P., Shepherd G. R., Hardin J. M., Noland B. J. (1972) Arch. Biochem. Biophys. 148, 558–567 [DOI] [PubMed] [Google Scholar]
- 7.Morillon A., Karabetsou N., Nair A., Mellor J. (2005) Mol. Cell 18, 723–734 [DOI] [PubMed] [Google Scholar]
- 8.Barski A., Cuddapah S., Cui K., Roh T. Y., Schones D. E., Wang Z., Wei G., Chepelev I., Zhao K. (2007) Cell 129, 823–837 [DOI] [PubMed] [Google Scholar]
- 9.Wang Z., Zang C., Rosenfeld J. A., Schones D. E., Barski A., Cuddapah S., Cui K., Roh T. Y., Peng W., Zhang M. Q., Zhao K. (2008) Nat. Genet. 40, 897–903 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bonenfant D., Coulot M., Towbin H., Schindler P., van Oostrum J. (2006) Mol. Cell. Proteomics 5, 541–552 [DOI] [PubMed] [Google Scholar]
- 11.Pesavento J. J., Kim Y. B., Taylor G. K., Kelleher N. L., (2004) J. Am. Chem. Soc. 126, 3386–3387 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Garcia B. A., Pesavento J. J., Mizzen C. A., Kelleher N. L. (2007) Nat. Methods 4, 487–489 [DOI] [PubMed] [Google Scholar]
- 13.Tagami H., Ray-Gallet D., Almouzni G., Nakatani Y. (2004) Cell 116, 51–61 [DOI] [PubMed] [Google Scholar]
- 14.Prior C. P., Cantor C. R., Johnson E. M., Allfrey V. G. (1980) Cell 20, 597–608 [DOI] [PubMed] [Google Scholar]
- 15.Jackson V., Chalkley R., (1985) Biochemistry 24, 6930–6938 [DOI] [PubMed] [Google Scholar]
- 16.Yamasu K., Senshu T. (1990) J. Biochem. 107, 15–20 [DOI] [PubMed] [Google Scholar]
- 17.Leffak I. M. (1984) Nature 307, 82–85 [DOI] [PubMed] [Google Scholar]
- 18.Xu M., Long C., Chen X., Huang C., Chen S., Zhu B. (2010) Science 328, 94–98 [DOI] [PubMed] [Google Scholar]
- 19.Sogo J. M., Stahl H., Koller T., Knippers R. (1986) J. Mol. Biol. 189, 189–204 [DOI] [PubMed] [Google Scholar]
- 20.Pesavento J. J., Yang H., Kelleher N. L., Mizzen C. A. (2008) Mol. Cell. Biol. 28, 468–486 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zee B. M., Levin R. S., Xu B., LeRoy G., Wingreen N. S., Garcia B. A. (2010) J. Biol. Chem. 285, 3341–3350 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Scharf A. N., Barth T. K., Imhof A. (2009) Nucleic Acids Res. 37, 5032–5040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ong S. E., Mittler G., Mann M. (2004) Nat. Methods 1, 119–126 [DOI] [PubMed] [Google Scholar]
- 24.Feng Q., Wang H., Ng H. H., Erdjument-Bromage H., Tempst P., Struhl K., Zhang Y. (2002) Curr. Biol. 12, 1052–1058 [DOI] [PubMed] [Google Scholar]
- 25.van Leeuwen F., Gafken P. R., Gottschling D. E. (2002) Cell 109, 745–756 [DOI] [PubMed] [Google Scholar]
- 26.Shahbazian M. D., Zhang K., Grunstein M., Histone H. (2005) Mol. Cell 19, 271–277 [DOI] [PubMed] [Google Scholar]
- 27.Briggs S. D., Xiao T., Sun Z. W., Caldwell J. A., Shabanowitz J., Hunt D. F., Allis C. D., Strahl B. D. (2002) Nature 418, 498–498 [DOI] [PubMed] [Google Scholar]
- 28.Ng H. H., Xu R. M., Zhang Y., Struhl K. (2002) J. Biol. Chem. 277, 34655–34657 [DOI] [PubMed] [Google Scholar]
- 29.Kim J., Hake S. B., Roeder R. G. (2005) Mol. Cell 20, 759–770 [DOI] [PubMed] [Google Scholar]
- 30.Loyola A., Bonaldi T., Roche D., Imhof A., Almouzni G. (2006) Mol. Cell 24, 309–316 [DOI] [PubMed] [Google Scholar]
- 31.Siuti N., Kelleher N. L. (2010) Anal. Biochem. 396, 180–187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Thomas C. E., Kelleher N. L., Mizzen C. A. (2006) J. Proteome Res. 5, 240–247 [DOI] [PubMed] [Google Scholar]
- 33.Schulze J. M., Jackson J., Nakanishi S., Gardner J. M., Hentrich T., Haug J., Johnston M., Jaspersen S. L., Kobor M. S., Shilatifard A. (2009) Mol. Cell 35, 626–641 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Sarraf S. A., Stancheva I. (2004) Mol. Cell 15, 595–605 [DOI] [PubMed] [Google Scholar]
- 35.Steger D. J., Lefterova M. I., Ying L., Stonestrom A. J., Schupp M., Zhuo D., Vakoc A. L., Kim J. E., Chen J., Lazar M. A., Blobel G. A., Vakoc C. R. (2008) Mol. Cell. Biol. 28, 2825–2839 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zhang Y., Shin H., Song J. S., Lei Y., Liu X. S. (2008) BMC Genomics 9, 537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kumar S., Leffak M. (1986) Biochemistry 25, 2055–2060 [DOI] [PubMed] [Google Scholar]
- 38.Karlić R., Chung H. R., Lasserre J., Vlahovicek K., Vingron M. (2010) Proc. Natl. Acad. Sci. 107, 2926–2931 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Copeland R. A., Solomon M. E., Richon V. M., (2009) Nat. Rev. Drug. Discov. 8, 724–732 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.












